BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11864540)

  • 1. [Recommendations for the use of infliximab (Remicade) in Crohn's disease. GETECCU 2001].
    Domènech E; Esteve-Comas M; Gomollón F; Hinojosa J; Obrador A; Panés J; Gassull MA;
    Gastroenterol Hepatol; 2002 Mar; 25(3):162-9. PubMed ID: 11864540
    [No Abstract]   [Full Text] [Related]  

  • 2. Infliximab (Remicade): the magic bullet for Crohn's disease?
    D'Haens G
    Dig Liver Dis; 2000 Nov; 32(8):653-6. PubMed ID: 11142571
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic amyloidosis with Crohn's disease treated with infliximab.
    Park YK; Han DS; Eun CS
    Inflamm Bowel Dis; 2008 Mar; 14(3):431-2. PubMed ID: 17932971
    [No Abstract]   [Full Text] [Related]  

  • 4. Canadian Association of Gastroenterology Clinical Practice Guidelines: the use of infliximab in Crohn's disease.
    Panaccione R; Fedorak RN; Aumais G; Bernstein CN; Bitton A; Croitoru K; Enns R; Feagan B; Fishman M; Greenberg G; Griffiths A; Marshall JK; Rasul I; Sadowski D; Seidman E; Steinhart H; Sutherland L; Walli E; Wild G; Williams CN; Zachos M;
    Can J Gastroenterol; 2004 Aug; 18(8):503-8. PubMed ID: 15372114
    [No Abstract]   [Full Text] [Related]  

  • 5. [Remicade (infliximab) in the treatment of Crohn disease].
    Brazier F; Delcenserie R; Dupas JL
    Presse Med; 2000 Sep; 29(16):1463-4. PubMed ID: 11039091
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of infliximab in the treatment of Crohn's disease in children and adolescents.
    Hyams JS
    J Pediatr Gastroenterol Nutr; 2001 Sep; 33 Suppl 1():S36-9. PubMed ID: 11685974
    [No Abstract]   [Full Text] [Related]  

  • 7. Infliximab (Remicade), a new biological treatment for Crohn's disease.
    D'Haens GR
    Ital J Gastroenterol Hepatol; 1999; 31(6):519-20. PubMed ID: 10575573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discussion on predictors of response to infliximab in patients with Crohn's disease.
    Hommes D
    Gastroenterology; 2003 Jun; 124(7):2002-3. PubMed ID: 12812196
    [No Abstract]   [Full Text] [Related]  

  • 9. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. A BALANCING VIEW: lifetime channeling of infliximab for crohn's disease.
    Hanauer SB
    Am J Gastroenterol; 2005 Jul; 100(7):1438-9. PubMed ID: 15984961
    [No Abstract]   [Full Text] [Related]  

  • 10. Safe use of infliximab for the treatment of fistulizing Crohn's disease during pregnancy within 3 months of conception.
    Angelucci E; Cocco A; Viscido A; Caprilli R
    Inflamm Bowel Dis; 2008 Mar; 14(3):435-6. PubMed ID: 18050300
    [No Abstract]   [Full Text] [Related]  

  • 11. [Indications and results of infliximab in Crohn's disease].
    Karoui S; Boubaker J; Filali A
    Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab treatment for Crohn's disease.
    Conroy CA; Cattell R
    Postgrad Med J; 2001 Jul; 77(909):436-40. PubMed ID: 11423591
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of treatment with chimeric monoclonal antibody (Infliximab) to tumor necrosis factor-alpha for Crohn's disease in Japan: evaluation by rapid turnover proteins, and radiologic and endoscopic findings.
    Asakura H; Yao T; Matsui T; Koganei K; Fukushima T; Takazoe M; Hobara R; Nakano H; Okamura S; Matsueda K; Kashida H; Makiyama K; Hiwatashi N; Kashiwagi K; Hibi T
    J Gastroenterol Hepatol; 2001 Jul; 16(7):763-9. PubMed ID: 11446884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Maintenance therapy with biologic agents for Crohn's disease: impact of scheduled maintenance therapy with infliximab].
    Endo K; Shiga H; Kakuta Y; Takahashi S; Kinouchi Y; Shimosegawa T
    Nihon Shokakibyo Gakkai Zasshi; 2011 Mar; 108(3):401-9. PubMed ID: 21389661
    [No Abstract]   [Full Text] [Related]  

  • 15. Infliximab: how to use it in pediatric Crohn's disease.
    Ruemmele FM
    J Pediatr Gastroenterol Nutr; 2004 Jul; 39(1):12-4. PubMed ID: 15187774
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolonged duration of response to infliximab in early pediatric Crohn's disease.
    Kugathasan S
    J Pediatr Gastroenterol Nutr; 2001 Sep; 33 Suppl 1():S40-3. PubMed ID: 11685975
    [No Abstract]   [Full Text] [Related]  

  • 17. Infliximab.
    Valle E; Gross M; Bickston SJ
    Expert Opin Pharmacother; 2001 Jun; 2(6):1015-25. PubMed ID: 11585004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody therapy for Crohn's disease.
    Selby W
    Intern Med J; 2001 Mar; 31(2):73-4. PubMed ID: 11480481
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease.
    Kugathasan S; Werlin SL; Martinez A; Rivera MT; Heikenen JB; Binion DG
    Am J Gastroenterol; 2000 Nov; 95(11):3189-94. PubMed ID: 11095340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal vein thrombosis after infliximab (Remicade) treatment for Crohn's disease.
    Puli SR; Benage DD
    Am J Gastroenterol; 2003 Apr; 98(4):939-40. PubMed ID: 12738486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.